T1	p 77 108	treated hypertensive patients .
T2	p 275 321	hypertensive patients receiving drug treatment
T3	p 785 1005	people with one or more cardiovascular risk factors . Fifteen Italian hypertension units studied 142 hypertensive patients ( 76 men , 66 women ; mean age 59 +/- 5.9 years ) treated with different antihypertensive drugs :
T4	i 17 33	low-dose aspirin
T5	i 195 230	Nonsteroidal antiinflammatory drugs
T6	i 351 367	low-dose aspirin
T7	i 439 459	low doses of aspirin
T8	i 562 605	chronic , stable antihypertensive therapy .
T9	i 761 768	aspirin
T10	i 772 781	vitamin E
T11	i 981 1005	antihypertensive drugs :
T12	i 1037 1044	aspirin
T13	i 1062 1072	controls .
T14	i 1226 1233	aspirin
T15	i 1414 1421	aspirin
T16	i 1681 1688	aspirin
T17	i 1707 1728	antihypertensive drug
T18	i 1737 1779	( angiotensin converting enzyme inhibitors
T19	i 1784 1805	calcium antagonists )
T20	i 1915 1922	aspirin
T21	o 37 73	clinic and ambulatory blood pressure
T22	o 242 271	blood pressure ( BP ) control
T23	o 478 541	clinic and ambulatory systolic ( SBP ) and diastolic ( DBP ) BP
T24	o 1098 1153	clinic BP evaluation with an automatic sphygmomanometer
T25	o 1160 1189	24-h ambulatory BP monitoring
T26	o 1285 1303	clinic SBP and DBP
T27	o 1373 1395	Ambulatory SBP and DBP
T28	o 1926 1936	BP control